119th Congress · introduced in the Senate · Feb 12, 2025
Combating Illicit Xylazine Act
Official title from Congress.gov
Latest action (Apr 15, 2026): Placed on Senate Legislative Calendar under General Orders. Calendar No. 372.
View on Congress.govPolicy area: Crime and Law Enforcement
Congressional Research Service summary, version: Reported to Senate (Apr 15, 2026)
Combating Illicit Xylazine Act
This bill regulates xylazine under the Controlled Substances Act (CSA).
Xylazine, also known as tranq, is a nonopioid sedative and pain reliever that is approved for use in animals. Recently, the Drug Enforcement Administration (DEA) has reported an increase in trafficking of fentanyl mixed with xylazine.
This bill adds xylazine, including its salts, isomers, and salts of isomers, to schedule III of the CSA. Schedule III controlled substances, including anabolic steroids, buprenorphine, and ketamine, have less potential for abuse than a schedule I or II substance, have a currently accepted medical use, and have low or moderate risk of dependence if abused.
Under the bill, manufacturing, distributing, or dispensing xylazine, or possessing with intent to manufacture, distribute, or dispense xylazine for illicit use is subject to criminal penalties under the CSA. The bill also requires xylazine transactions to be tracked in the drug reporting system maintained by the DEA.
The bill exempts from registration under the CSA persons and entities that possess xylazine (1) lawfully dispensed by a veterinarian or pharmacy and (2) for an animal or for use in certain animal-control or wildlife programs.
Show the full summary (2 more paragraphs)Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Placed on Senate Legislative Calendar under General Orders. Calendar No. 372.
Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.
Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
Read twice and referred to the Committee on the Judiciary.
Introduced in Senate
Actions from Congress.gov, newest first.
Congressional oversight · Consumer affairs · Criminal procedure and sentencing · Drug safety, medical device, and laboratory regulation · Drug trafficking and controlled substances · Licensing and registrations · Manufacturing · U.S. Sentencing Commission · Veterinary medicine and animal diseases
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 24, 2026.
26 citations; showing the 25 most recently posted.
PEACE OFFICERS RESEARCH ASSOCIATION OF CALIFORNIA · lobbying firm or registrant: STEPTOE LLP
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Alcohol and Drug Abuse
$50,000
Paid to lobbying firm
Combating Illicit Xylazine Act (H.R. 1266 / S. 545); Targeting Online Sales of Fentanyl Act (H.R. 5744); Combating Fentanyl Poisonings Act of 2025 (H.R. 5573); Ending Drug Trafficking in Our Communities Act (H.…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE SENTENCING PROJECT · lobbying firm or registrant: THE SENTENCING PROJECT
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
Amount not reported
…Oppose S. 3397ECCHO Act Oppose S. 3394SAFE Act Oppose S. 1572Federal Carjacking Enforcement Act Oppose H.R. 5415 /S. 3076Nitazene Control Act Oppose H.R. 1266/S. 545Combating Illicit Xylazine Act Oppose H.R. 7970STOP Nitazenes Act Oppose
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. View filing
SERGEANTS BENEVOLENT ASSOCIATION OF NEW YORK CITY · lobbying firm or registrant: LONGBOW PUBLIC POLICY GROUP, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 16, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$40,000
Paid to lobbying firm
…nse for motor vehicle collision fraud; entire bill. H.R. 1266, the "Combatting Illicit Xylazine Act," a bill to prohibit certain uses of xylazine; entire bill. S. 545, the "Combatting Illicit Xylazine Act," a bill to prohibit certain uses of xylazine; entire bill.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL ASSOCIATION OF CRIMINAL DEFENSE LAWYERS (NACDL) · lobbying firm or registrant: NATIONAL ASSOCIATION OF CRIMINAL DEFENSE LAWYERS (NACDL)
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 13, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$15,000
Spent on own lobbying
Cannabis Administration and Opportunity Act (CAOA) (S. 5022); Cashless Bail Reporting Act (H.R. 5625); Combating Illicit Xylazine Act (S. 545/H.R. 1266); Combating Organized Retail Crime Act (CORCA) (S. 1404/H.R. 2853); Continuing Appropriations / temporary funding extension (H.R. 6500); District of…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DUE PROCESS INSTITUTE · lobbying firm or registrant: DUE PROCESS INSTITUTE
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Aug 13, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$15,000
Spent on own lobbying
…or weak mens rea protections or those that result in overly harsh incarcerative penalties) in general; opposing the Combating Illicit Xylazine Act (H.R. 1266 / S.545); supporting the Due Process Continuity of Care Act (H.R.1510 / S.1720); supporting sufficient funding for the implementation of the Federal Prison Oversight A…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE SENTENCING PROJECT · lobbying firm or registrant: THE SENTENCING PROJECT
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$14,111
Spent on own lobbying
…Oppose S. 3397ECCHO Act Oppose S. 3394SAFE Act Oppose S. 1572Federal Carjacking Enforcement Act Oppose H.R. 5415 /S. 3076Nitazene Control Act Oppose H.R. 1266/S. 545Combating Illicit Xylazine Act Oppose H.R. 7970STOP Nitazenes Act Oppose
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PEACE OFFICERS RESEARCH ASSOCIATION OF CALIFORNIA · lobbying firm or registrant: STEPTOE LLP
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 19, 2026 · issue area: Alcohol and Drug Abuse
$50,000
Paid to lobbying firm
Combating Illicit Xylazine Act (H.R. 1266 / S. 545); Targeting Online Sales of Fentanyl Act (H.R. 5744); Combating Fentanyl Poisonings Act of 2025 (H.R. 5573); Ending Drug Trafficking in Our Communities Act (H.…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DRUG POLICY ALLIANCE · lobbying firm or registrant: DRUG POLICY ALLIANCE
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 17, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$18,639
Spent on own lobbying
…gress to support and co-sponsor the Cannabis Administration and Opportunity Act in the Senate. We urged Congress to oppose the Combating Xylazine Act(H.R. 1266/S. 545), Nitazene Control Act (H.R. 5415 /S. 3076), and STOP Nitazenes Act (H.R. 7970).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL ASSOCIATION OF CRIMINAL DEFENSE LAWYERS (NACDL) · lobbying firm or registrant: NATIONAL ASSOCIATION OF CRIMINAL DEFENSE LAWYERS (NACDL)
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 14, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$15,000
Spent on own lobbying
Combatting Illicit Xylazine Act (H.R. 1266, S. 545); Federal Carjacking Enforcement Act (H.R. 6155, S. 1572); Make the District of Columbia Safe and Beautiful Act of 2025 (H.R. 5103); Combating Organized Retail…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SERGEANTS BENEVOLENT ASSOCIATION OF NEW YORK CITY · lobbying firm or registrant: LONGBOW PUBLIC POLICY GROUP, LLC
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 10, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$40,000
Paid to lobbying firm
…g certain commercially available information that is used to generate investigative leads, identify threats, and locate victims during criminal investigations. S. 545, the "Combatting Illicit Xylazine Act," a bill to prohibit certain uses of xylazine; entire bill. S. 4784, the FY 2027 National Defense Authorization Act, a bi…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DUE PROCESS INSTITUTE · lobbying firm or registrant: DUE PROCESS INSTITUTE
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Jun 1, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$15,000
Spent on own lobbying
…or weak mens rea protections or those that result in overly harsh incarcerative penalties) in general; opposing the Combating Illicit Xylazine Act (H.R. 1266 / S.545); supporting the Due Process Continuity of Care Act (H.R.1510 / S.1720); supporting sufficient funding for the implementation of the Federal Prison Oversight A…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE SENTENCING PROJECT · lobbying firm or registrant: THE SENTENCING PROJECT
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$17,342
Spent on own lobbying
…Oppose S. 3397ECCHO Act Oppose S. 3394SAFE Act Oppose S. 1572Federal Carjacking Enforcement Act Oppose H.R. 5415 /S. 3076Nitazene Control Act Oppose H.R. 1266/S. 545Combating Illicit Xylazine Act Oppose H.R. 7970STOP Nitazenes Act Oppose
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DRUG POLICY ALLIANCE · lobbying firm or registrant: DRUG POLICY ALLIANCE
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 19, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
Amount not reported
We urged Congress to support and co-sponsor the MORE Act (H.R. 5068). We urged Congress to oppose the Combating Xylazine Act(H.R. 1266/S. 545), Nitazene Control Act (H.R. 5415 /S. 3076), and STOP Nitazenes Act (H.R. 7970).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. View filing
PEACE OFFICERS RESEARCH ASSOCIATION OF CALIFORNIA · lobbying firm or registrant: STEPTOE LLP
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 19, 2026 · issue area: Alcohol and Drug Abuse
$50,000
Paid to lobbying firm
Combating Illicit Xylazine Act (H.R. 1266 / S. 545); Targeting Online Sales of Fentanyl Act (H.R. 5744); Combating Fentanyl Poisonings Act of 2025 (H.R. 5573); Ending Drug Trafficking in Our Communities Act (H.…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SERGEANTS BENEVOLENT ASSOCIATION OF NEW YORK CITY · lobbying firm or registrant: LONGBOW PUBLIC POLICY GROUP, LLC
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 10, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$40,000
Paid to lobbying firm
…forcement Officers Safety Act of 2004; entire bill. H.R. 1266, the "Combatting Illicit Xylazine Act," a bill to prohibit certain uses of xylazine; entire bill. S. 545, the "Combatting Illicit Xylazine Act," a bill to prohibit certain uses of xylazine; entire bill. S. 167, the "Protect and Serve Act," a bill to amend title 18…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL ASSOCIATION OF CRIMINAL DEFENSE LAWYERS (NACDL) · lobbying firm or registrant: NATIONAL ASSOCIATION OF CRIMINAL DEFENSE LAWYERS (NACDL)
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 7, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$15,000
Spent on own lobbying
…Reform Act (H.R. 5214); Safer Supervision Act (S. 3077); Smarter Pretrial Detention for Drug Charges Act (S. 3960); Combatting Illicit Xylazine Act(H.R. 1266, S. 545); STOP Nitazenes Act (H.R. 7970); FY2027 Commerce, Justice, Science and Related Agencies appropriations bill (mental health funding); Proposed amendments to th…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DUE PROCESS INSTITUTE · lobbying firm or registrant: DUE PROCESS INSTITUTE
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Feb 25, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$10,000
Spent on own lobbying
…or weak mens rea protections or those that result in overly harsh incarcerative penalties) in general; opposing the Combating Illicit Xylazine Act (H.R. 1266 / S.545); supporting the Due Process Continuity of Care Act (H.R.1510 / S.1720); supporting sufficient funding for the implementation of the Federal Prison Oversight A…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PEACE OFFICERS RESEARCH ASSOCIATION OF CALIFORNIA · lobbying firm or registrant: STEPTOE LLP
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 20, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$50,000
Paid to lobbying firm
…Marc Fischer Memorial Interdiction of Fentanyl in Postal Mail at Federal Prisons Act / BOP SCAN Mail Act (S. 1295, H.R. 1046); Combating Illicit Xylazine Act (S. 545, H.R. 1266); Prosecutors Need to Prosecute Act (S. 234, H.R. 350); Combating Organized Retail Crime Act (S. 1404, H.R. 2853); HIRRE Prosecutors Act; Supporting…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DUE PROCESS INSTITUTE · lobbying firm or registrant: DUE PROCESS INSTITUTE
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 23, 2025 · issue area: Law Enforcement/Crime/Criminal Justice
$40,000
Spent on own lobbying
…or weak mens rea protections or those that result in overly harsh incarcerative penalties) in general; opposing the Combating Illicit Xylazine Act (H.R. 1266 / S.545); supporting the Due Process Continuity of Care Act (H.R.1510 / S.1720); supporting sufficient funding for the implementation of the Federal Prison Oversight A…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PEACE OFFICERS RESEARCH ASSOCIATION OF CALIFORNIA · lobbying firm or registrant: STEPTOE LLP
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 20, 2025 · issue area: Law Enforcement/Crime/Criminal Justice
$50,000
Paid to lobbying firm
…Marc Fischer Memorial Interdiction of Fentanyl in Postal Mail at Federal Prisons Act / BOP SCAN Mail Act (S. 1295, H.R. 1046); Combating Illicit Xylazine Act (S. 545, H.R. 1266); Prosecutors Need to Prosecute Act (S. 234, H.R. 350); Combating Organized Retail Crime Act (S. 1404, H.R. 2853); HIRRE Prosecutors Act; Supporting…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DUE PROCESS INSTITUTE · lobbying firm or registrant: DUE PROCESS INSTITUTE
2025 Q2 report (Apr 1, 2025 – Jun 30, 2025) · posted Aug 21, 2025 · issue area: Law Enforcement/Crime/Criminal Justice
$40,000
Spent on own lobbying
…or weak mens rea protections or those that result in overly harsh incarcerative penalties) in general; opposing the Combating Illicit Xylazine Act, H.R. 1266 / S.545; supporting the Due Process Continuity of Care Act, H.R.1510; supporting sufficient funding for the implementation of the Federal Prison Oversight Act; support…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PEACE OFFICERS RESEARCH ASSOCIATION OF CALIFORNIA · lobbying firm or registrant: STEPTOE LLP
2025 Q2 report (Apr 1, 2025 – Jun 30, 2025) · posted Jul 20, 2025 · issue area: Law Enforcement/Crime/Criminal Justice
$50,000
Paid to lobbying firm
…Marc Fischer Memorial Interdiction of Fentanyl in Postal Mail at Federal Prisons Act / BOP SCAN Mail Act (S. 1295, H.R. 1046); Combating Illicit Xylazine Act (S. 545, H.R. 1266); Prosecutors Need to Prosecute Act (S. 234, H.R. 350); Combating Organized Retail Crime Act (S. 1404, H.R. 2853); HIRRE Prosecutors Act; Supporting…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DUE PROCESS INSTITUTE · lobbying firm or registrant: DUE PROCESS INSTITUTE
2025 Q1 report (Jan 1, 2025 – Mar 31, 2025) · posted Jul 9, 2025 · issue area: Law Enforcement/Crime/Criminal Justice
$40,000
Spent on own lobbying
…or weak mens rea protections or those that result in overly harsh incarcerative penalties) in general; opposing the Combating Illicit Xylazine Act, H.R. 1266 / S.545; and supporting the Due Process Continuity of Care Act, H.R.1510.
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PENNSYLVANIA FARM BUREAU · lobbying firm or registrant: PENNSYLVANIA FARM BUREAU
2025 Q1 report (Jan 1, 2025 – Mar 31, 2025) · amended · posted Apr 30, 2025 · issue area: Animals
$10,000
Spent on own lobbying
…from APHIS compensation program, rather than only flocks that test positive. - Supported Secretary Rollins' February 2025 5 pronged approach to combat HPAI. - S.545/H.R.1266, the Combating Illicit Xylazine Act, which would schedule xylazine as a controlled substance. - H.R.845, the Pets and Livestock Protection Act, which…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PEACE OFFICERS RESEARCH ASSOCIATION OF CALIFORNIA · lobbying firm or registrant: STEPTOE LLP
2025 Q1 report (Jan 1, 2025 – Mar 31, 2025) · posted Apr 21, 2025 · issue area: Law Enforcement/Crime/Criminal Justice
$50,000
Paid to lobbying firm
…Marc Fischer Memorial Interdiction of Fentanyl in Postal Mail at Federal Prisons Act / BOP SCAN Mail Act (S. 1295, H.R. 1046); Combating Illicit Xylazine Act (S. 545, H.R. 1266); Prosecutors Need to Prosecute Act (S. 234, H.R. 350); Combating Organized Retail Crime Act (S. 1404, H.R. 2853); HIRRE Prosecutors Act; Supporting…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing